Study on Improvement of Screening Quality by Having a Medical Statistics Expert on IRB
スポンサーリンク
概要
- 論文の詳細を見る
At Kinki University Hospital,the Institutional Review Board (IRB) was established in 1989 at the time that Good Clinical Practice (GCP) was introduced and since then,it has screened the clinical trials and clinical studies conducted by physicians and the number of persons in the screening committee has been increased.In April,2005,a medical statistician was assigned to the board and preliminary screening was started for clinical studies,which has reinforced the screening process.In the present study,we determined how the content of IRB screening has changed in accordance with responses made to recommendations made by the IRB,finding that the number of recommendations by the IRB had increased 1.88-fold for clinical trials and 4.62-fold for clinical studies.The fact that they covered everything from ethical to scientific aspects indicated the highly significant role they had played.Upon classifying IRB recommendations into three categories : ethical recommendations,scientific recommendations,reliability-related and other recommendations,we found that there had been a sharp increase in scientific recommendations and that there was room for improvement in statistical screening for clinical studies conducted by physicians.The above findings demonstrate the effectiveness of the participation of a medical statistician in the IRB.We would also like to point out the importance of the person responsible for the preparation of IRB minutes (usually a pharmacist) having a knowledge of the scientific aspects of protocols,statistical aspects in particular.
- 日本医療薬学会の論文
日本医療薬学会 | 論文
- O17-003 視覚障害者に対する手技指導の標準化を目的とした視覚障害擬似体験インスリン注射院内実習(一般演題 口頭発表,糖尿病/後発医薬品,医療薬学の創る未来 科学と臨床の融合)
- 20H-16 Basal-Bolus療法におけるインスリンデテミルの有効性(使用状況調査・意識調査,来るべき時代への道を拓く)
- 30-P2-43 2種類のインスリン試薬を用いた化学発光酵素免疫測定法によってFactitious hypoglicemiaを証明しえた一例(副作用・有害事象,社会の期待に応える医療薬学を)
- 28-04-20 ペン型インスリン注射器の精度に及ぼす注入時抵抗とカートリッジ内気泡の影響
- P-610 ファブリー病に対する「ファブラザイム^[○!R]」投与時の「過敏反応発現時の対処方法」の一部改変により副作用防止に至った1症例(8.有害事象・副作用(基礎と臨床)1,医療薬学の未来へ翔(はばた)く-薬剤師の薬剤業務・教育・研究への能動的関わり-)